This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Gradient Denervation Technologies Sas. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations by William Cannon in Pulmonary Denervation Technologies
Introduction
William Cannon is an accomplished inventor based in County Galway, Ireland. He has made significant contributions to the field of medical technology, particularly in the area of pulmonary denervation. With a total of 3 patents, his work focuses on innovative systems and methods that aim to improve patient outcomes in cardiovascular health.
Latest Patents
Cannon's latest patents include groundbreaking technologies for applying energy to denervate a pulmonary artery. One of his notable inventions is a catheter system designed for the ablation of tissue around a blood vessel, specifically the pulmonary artery. This system aims to reduce the neural activity of nerves surrounding the blood vessel. The catheter features an elongate shaft with a proximal portion coupled to a handle and a distal portion that includes a transducer and an expandable anchor. The anchor can transition between a collapsed delivery state and an expanded deployed state, centralizing the transducer within the blood vessel. The transducer emits energy to effectively reduce neural activity, and additional systems and methods are provided to confirm that the neural activity has been sufficiently reduced.
Career Highlights
William Cannon is currently associated with Gradient Denervation Technologies SAS, where he continues to develop innovative solutions in the medical field. His expertise and dedication to advancing technology in pulmonary health have positioned him as a key figure in this specialized area.
Collaborations
Cannon collaborates with talented professionals such as David Amaoua and Martin Grasse, who contribute to the development and refinement of his innovative technologies.
Conclusion
William Cannon's contributions to pulmonary denervation technologies exemplify the impact of innovation in medical science. His patents reflect a commitment to improving healthcare through advanced engineering solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile